Literature DB >> 6531749

A Glanzmann's thrombasthenia cluster among Iraqi Jews in Israel.

U Seligsohn, S Rososhansky.   

Abstract

A country-wide survey of Glanzmann's thrombasthenia in Israel identified 44 patients. The patients belong to 23 unrelated families, 17 of whom are of Iraqi Jewish origin. The frequency of thrombasthenia among Iraqi Jews in Israel (total population 270,000) is 1:7714 and thus the calculated frequency of the carrier state is 2.3%.

Entities:  

Mesh：

Year:  1984        PMID： 6531749

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


  13 in total

1.  Clinical utility gene card for: Glanzmann thrombasthenia.

Authors:  Mathieu Fiore; Alan T Nurden; Paquita Nurden; Uri Seligsohn
Journal:  Eur J Hum Genet       Date:  2012-07-11       Impact factor: 4.246

Review 2.  Recombinant factor VIIa (Eptacog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders.

Authors:  M Asif A Siddiqui; Lesley J Scott
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Founder effect and estimation of the age of the French Gypsy mutation associated with Glanzmann thrombasthenia in Manouche families.

Authors:  Mathieu Fiore; Xavier Pillois; Paquita Nurden; Alan T Nurden; Frédéric Austerlitz
Journal:  Eur J Hum Genet       Date:  2011-04-13       Impact factor: 4.246

4.  The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel.

Authors:  P J Newman; U Seligsohn; S Lyman; B S Coller
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Clinical and molecular insights into Glanzmann's thrombasthenia in China.

Authors:  L Zhou; M Jiang; H Shen; T You; Z Ding; Q Cui; Z Ma; F Yang; Z Xie; H Shi; J Su; L Cao; J Lin; J Yin; L Dai; H Wang; Z Wang; Z Yu; C Ruan; L Xia
Journal:  Clin Genet       Date:  2018-05-22       Impact factor: 4.438

6.  Specifications of the variant curation guidelines for ITGA2B/ITGB3: ClinGen Platelet Disorder Variant Curation Panel.

Authors:  Justyne E Ross; Bing M Zhang; Kristy Lee; Shruthi Mohan; Brian R Branchford; Paul Bray; Stefanie N Dugan; Kathleen Freson; Paula G Heller; Walter H A Kahr; Michele P Lambert; Lori Luchtman-Jones; Minjie Luo; Juliana Perez Botero; Matthew T Rondina; Gabriella Ryan; Sarah Westbury; Wolfgang Bergmeier; Jorge Di Paola
Journal:  Blood Adv       Date:  2021-01-26

7.  A 13-bp deletion in alpha(IIb) gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombasthenia.

Authors:  N Rosenberg; H Hauschner; H Peretz; R Mor-Cohen; M Landau; B Shenkman; G Kenet; B S Coller; A A Awidi; U Seligsohn
Journal:  J Thromb Haemost       Date:  2005-12       Impact factor: 5.824

8.  Glanzmann's thrombasthenia with mild von Willebrand's disease.

Authors:  R Nounou; D Spence
Journal:  J Clin Pathol       Date:  1993-12       Impact factor: 3.411

9.  A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.

Authors:  B S Coller
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

10.  Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.

Authors:  T Yasuda; H K Gold; J T Fallon; R C Leinbach; J L Guerrero; L E Scudder; M Kanke; D Shealy; M J Ross; D Collen; B S Coller
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.